BLLN - Billiontoone Inc.

94.23
-11.710   -12.427%

Share volume: 1,287,603
Last Updated: 05-12-2026
Healthcare/Services – Health: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$105.94
-11.71
-0.11%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
69%
Profitability 73%
Dept financing 41%
Liquidity 75%
Performance 71%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.37%
1 Month
19.73%
3 Months
6.34%
6 Months
5.23%
1 Year
-13.50%
2 Year
-13.50%
Key data
Stock price
$94.23
P/E Ratio 
0.00
DAY RANGE
$93.45 - $102.90
EPS 
$0.53
52 WEEK RANGE
$61.96 - $138.70
52 WEEK CHANGE
-$13.50
MARKET CAP 
4.186 B
YIELD 
N/A
SHARES OUTSTANDING 
45.995 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$1,130,529
AVERAGE 30 VOLUME 
$633,770
Company detail
CEO: Oguzhan Atay
Region: US
Website: www.billiontoone.com
Employees: 620
IPO year: 2025
Issue type:
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

BillionToOne is transforming healthcare by redefining molecular diagnostics. Our revolutionary single molecule NGS (smNGS) platform achieves what was once thought impossible – detecting and precisely quantifying genetic targets with single-molecule sensitivity. At the heart of this technological breakthrough lies our patented QCTs, enabling measurements at the physical limit of detection – the single DNA molecule. Our principal executive offices are located in Menlo Park, CA.

Recent news